These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 16079110

  • 1. Risk factors for Gram-negative bacterial infections in febrile neutropenia.
    Cordonnier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G, Bastuji-Garin S, Club de Réflexion sur les Infections en Onco-Hématologie group.
    Haematologica; 2005 Aug; 90(8):1102-9. PubMed ID: 16079110
    [Abstract] [Full Text] [Related]

  • 2. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M, Thamlikitkul V.
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.
    Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, Bastuji-Garin S, Club de Réflexion sur les Infections en Onco-Hématologie.
    Clin Infect Dis; 2003 Jan 15; 36(2):149-58. PubMed ID: 12522746
    [Abstract] [Full Text] [Related]

  • 4. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun 15; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 5. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P, Suankratay C.
    J Med Assoc Thai; 2010 Jul 15; 93(7):776-83. PubMed ID: 20649055
    [Abstract] [Full Text] [Related]

  • 6. Bacteraemia in febrile neutropenic cancer patients.
    Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmans M.
    Int J Antimicrob Agents; 2007 Nov 15; 30 Suppl 1():S51-9. PubMed ID: 17689933
    [Abstract] [Full Text] [Related]

  • 7. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec 15; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for Gram-negative infections in neutropenic patients.
    Della Porta MG, Malcovati L.
    Haematologica; 2005 Aug 15; 90(8):1013C. PubMed ID: 16079097
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul 01; 115(1):7-12. PubMed ID: 2048868
    [Abstract] [Full Text] [Related]

  • 10. Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade.
    Kanafani ZA, Dakdouki GK, El-Chammas KI, Eid S, Araj GF, Kanj SS.
    Int J Infect Dis; 2007 Sep 01; 11(5):450-3. PubMed ID: 17337226
    [Abstract] [Full Text] [Related]

  • 11. Bloodstream infections in cancer patients with febrile neutropenia.
    Feld R.
    Int J Antimicrob Agents; 2008 Nov 01; 32 Suppl 1():S30-3. PubMed ID: 18778919
    [Abstract] [Full Text] [Related]

  • 12. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 01; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 13. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
    Kern WV, Heiss M, Steinbach G.
    Clin Infect Dis; 2001 Mar 01; 32(5):832-5. PubMed ID: 11229856
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [Abstract] [Full Text] [Related]

  • 20. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Ten Vergert EM, Vermeulen KM, de Vries-Hospers HG, de Bont ES.
    J Clin Oncol; 2005 Oct 20; 23(30):7437-44. PubMed ID: 16234511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.